| C14orf104/KTU |
Primary Ciliary Dyskinesia (PCD) |
aCGH |
612517 |
| C20orf54 |
Progressive Bulbar Palsy With or Without Sensorineural Deafness (Brown-Vialetto-van Laere Syndrome and Fazio-Londe Disease) |
|
613350 |
| CAPN3 |
Limb
Girdle Muscular Dystrophy, Type 2A |
aCGH |
114240 |
| |
Myositis,
eosinophilic |
aCGH |
114240 |
| CAV3 |
Caveolinopathy Testing |
aCGH |
601253 |
| CC2D2A |
Joubert and Meckel-Gruber Syndromes |
aCGH |
612013 |
| |
Joubert
Syndrome Sequential Test |
aCGH |
612013 |
| |
Meckel-Gruber Syndrome Sequencing Panel |
aCGH |
612013 |
| CCBE1 |
Hennekam Lymphangiectasia-Lymphedema Syndrome |
aCGH |
612753 |
| CCDC39 |
Primary Ciliary Dyskinesia (PCD) |
|
244400 |
| CCDC40 |
Primary Ciliary Dyskinesia (PCD) |
|
244400 |
| CCM1 |
KRIT1/CCM1 Gene Sequencing |
aCGH |
604214 |
| |
KRIT1/CCM1 "Common Hispanic" Mutation |
aCGH |
604214 |
| |
CCM Sequential Test |
aCGH |
604214 |
| CCM2 |
Cerebral
Cavernous Malformations |
aCGH |
607929 |
| |
CCM2
Exon 2-10 Deletion Test |
aCGH |
607929 |
| |
CCM Sequential Test |
aCGH |
604214 |
| CCM3 |
PDCD10/CCM3 Gene Sequencing |
aCGH |
603285 |
| |
CCM Sequential Test |
aCGH |
604214 |
| CDH23 |
Usher Syndrome Type 1 |
aCGH |
276900 |
| CDKN1B |
Multiple Endocrine Neoplasia Type 1 |
aCGH |
600778 |
| CEP290 |
Joubert
Syndrome |
aCGH |
610142 |
| |
Joubert
Syndrome Sequential Test |
aCGH |
610142 |
| |
Meckel-Gruber
Syndrome |
aCGH |
610142 |
| |
Meckel-Gruber Syndrome Sequencing Panel |
aCGH |
610142 |
| CFL2 |
Nemaline Myopathy 7 Skeletal Muscle Cofilin-2 Sequencing |
aCGH |
601443 |
| CFTR |
Cystic
Fibrosis and CBAVD Testing |
aCGH |
602421 |
| CHAT |
Congenital Myasthenic Syndrome with Episodic Apnea |
aCGH |
608931 |
| CHAT |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| CHEK2 |
Hereditary Breast Cancer |
|
604373 |
| CHD7 |
CHARGE
Syndrome |
aCGH |
608892 |
| CHRNA1 |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| |
Congenital Myasthenic Syndromes and Lethal Multiple Pterygium Syndrome |
aCGH |
100690 |
| |
Multiple Pterygium Syndromes |
aCGH |
253290 |
| CHRNB1 |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| |
Congenital Myasthenic Syndromes |
aCGH |
100710 |
| CHRND |
Congenital Myasthenic Syndromes and Lethal Multiple Pterygium Syndromes |
aCGH |
253290 |
| |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| |
Multiple Pterygium Syndromes |
aCGH |
253290 |
| CHRNE |
Congenital Myasthenic Syndrome |
aCGH |
608931 |
| |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| CHRNG |
Multiple Pterygium Syndromes |
aCGH |
253290 |
| CHRNG |
Multiple Pterygium Syndromes Panel |
aCGH |
253290 |
| CLRN1 |
Usher Syndrome Type 3 |
aCGH |
276902 |
| CNGA1 |
Retinitis Pigmentosa, Autosomal Recessive |
|
268000 |
| CNGA3 |
Achromatopsia |
aCGH |
600053 |
| CNGB1 |
Retinitis Pigmentosa, Autosomal Recessive |
aCGH |
600724 |
| CNGB3 |
Achromatopsia |
aCGH |
605080 |
| COL10A1 |
Metaphyseal Chondrodysplasia, Schmid Type (MCDS) |
|
156500 |
| COL11A1 |
Stickler Syndrome |
|
154780 |
| COL11A2 |
Stickler Syndrome, Type III, Otospondylomegaepiphyseal Dysplasia, Weissenbacher-Zweymuller Syndrome and Deafness, Autosomal Dominant 13 |
|
184840 |
| COL2A1 |
Achondrogenesis Type II (ACG2)-Hypochondrogenesis |
aCGH |
120140 |
| COL2A1 |
Kniest Dysplasia |
aCGH |
120140 |
| COL2A1 |
Osteoarthritis with Mild Chondrodysplasia |
aCGH |
604864 |
| COL2A1 |
Spondyloepiphyseal Dysplasia, Congenita (SEDc) and Spondylometaepiphyseal Dysplasia, Strudwick Type (SEMD) |
aCGH |
183900 |
| COL2A1 |
Spondyloperipheral Dysplasia (SPD) and Platyspondylic Lethal Skeletal Dysplasia, Torrance Type (PLSDT) |
aCGH |
271700 |
| COL2A1 |
Stickler Syndrome, Type 1 (STL1) |
aCGH |
108300 |
| COL3A1 |
Ehlers-Danlos Syndrome, Type IV |
|
130050 |
| COL5A1 |
Ehlers-Danlos Syndrome |
|
130010 |
| COL5A2 |
Ehlers-Danlos Syndrome |
|
130010 |
| COL6A1,
COL6A2, COL6A3 |
Type
6 Collagenopathy Testing (Ullrich Congenital Muscular Dystrophy
and Bethlem Myopathy) |
aCGH |
120220 |
| COL18A1 |
Knobloch Syndrome, Type I |
aCGH |
267750 |
| COL9A1 |
Stickler Syndrome, Autosomal Recessive |
aCGH |
120210 |
| |
Multiple Epiphyseal Dysplasia Panel |
aCGH |
226900 |
| COL9A2 |
Multiple Epiphyseal Dysplasia
| aCGH |
|
| |
Multiple Epiphyseal Dysplasia Panel |
aCGH |
226900 |
| COL9A3 |
Multiple Epiphyseal Dysplasia
| aCGH |
|
| |
Multiple Epiphyseal Dysplasia Panel |
aCGH |
226900 |
| COLQ |
Congenital Myasthenic Syndrome |
aCGH |
608931 |
| COLQ |
Congenital Myasthenic Syndrome Panel |
aCGH |
608931 |
| COMP |
Pseudoachondroplasia (PSACH) and Multiple Epiphyseal Dysplasia (MED) |
aCGH |
117170 |
| |
Multiple Epiphyseal Dysplasia Panel |
aCGH |
226900 |
| CPS1 |
Hyperammonemia |
aCGH |
608307 |
| CRB1 |
Leber Congenital Amaurosis and Retinitis Pigmentosa |
aCGH |
604210 |
| CRX |
Leber Congenital Amaurosis, Type VII |
aCGH |
602225 |
| CRYAB |
Myofibrillar Myopathy |
aCGH |
123590 |
| CSRP3 |
Hypertrophic Cardiomyopathy |
aCGH |
600824 |
| CTSC |
Papillon-Lefevre Syndrome (PLS) |
aCGH |
245000 |
| CUL4B |
Cabezas
X-Linked Mental Retardation Syndrome |
aCGH |
300304 |
| CUL7 |
3-M Syndrome | aCGH |
273750 |